<ENAMEX TYPE="ORGANIZATION">Bristol-Myers Squibb Co.</ENAMEX>, <ENAMEX TYPE="LOCATION">New York</ENAMEX>, the newly merged drug and health-care-product company, reported record third-quarter earnings for both companies in the merger.
<ENAMEX TYPE="ORGANIZATION">Bristol-Myers Co.</ENAMEX> and <ENAMEX TYPE="ORGANIZATION">Squibb Corp.</ENAMEX>, <ENAMEX TYPE="LOCATION">Princeton</ENAMEX>, <ENAMEX TYPE="LOCATION">N.J.</ENAMEX>, merged Oct. 4, but the new company reported third-period earnings for both companies. For the fourth quarter, <ENAMEX TYPE="ORGANIZATION">Bristol-Myers Squibb</ENAMEX> will report one set of earnings.
<ENAMEX TYPE="PERSON">Bristol-Myers</ENAMEX> said net income rose 15% to $266.2 million, or 93 cents a share, from $232.3 million, or 81 cents a share, a year earlier. Sales gained 5% to $1.59 billion from $1.52 billion.
<ENAMEX TYPE="ORGANIZATION">Squibb Corp.</ENAMEX> said net rose 17% to $144.5 million, or $1.47 a share, from $123 million, or $1.25 a share. Sales were $730.1 million, up 7% from $679.5 million.
In <ENAMEX TYPE="ORGANIZATION">New York Stock Exchange</ENAMEX> composite trading, <ENAMEX TYPE="PERSON">Bristol-Myers Squibb</ENAMEX> rose $1.75 to $52.75.
